Coherus Oncology, Inc. (CHRS)
1.61
+0.04
(+2.55%)
USD |
NASDAQ |
May 22, 16:00
1.615
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology Profit Margin (Quarterly) : -300.0% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 13.55% |
| Inovio Pharmaceuticals, Inc. | -- |
| Myriad Genetics, Inc. | -17.02% |
| Vaxart, Inc. | 13.20% |
| BioRestorative Therapies, Inc. | -9.29K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -527.2% |
| Return on Assets | -46.44% |
| Return on Invested Capital | -126.9% |
| Gross Profit Margin (Quarterly) | 61.86% |
| Operating Margin (Quarterly) | -293.7% |
| Return on Net Operating Assets | -204.8% |